Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Eamonn Hobbs
AddedMar 31, 2024
UpdatedMay 31, 2026
Eamonn Hobbs

Eamonn Hobbs

Founder, AngioDynamics

CrunchbaseLinkedIn

Eamonn Hobbs's Career

AngioDynamics
AngioDynamics

Latham, NY, US

Founder
OraSure Technologies
OraSure Technologies

Bethlehem, PA, US

Board Member· Board
Syncromune
Syncromune

Fort Lauderdale, FL, US

CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Eamonn Hobbs's Career

AngioDynamics
AngioDynamics
Public8151988Latham, NY, US
Founder

Leadership at AngioDynamics

Howard W. DonnellyHoward W. DonnellyBoard Member
Wes JohnsonWes JohnsonBoard Member
Jim ClemmerJim ClemmerBoard Member
Jan Stern ReedJan Stern ReedBoard Member

Similar to AngioDynamics

Angel Medical SystemsAngel Medical SystemsEatontown, NJ, USMedical Devicesest. 2001Angel Medical SystemsEatontown, NJ, US · est. 2001

Innovative medical organization in Eatontown, NJ, advancing patient care for High-Risk Coronary Artery Disease.

Series A · $88.6M66
Vascular DynamicsVascular DynamicsMountain View, CA, USMedical Devices, Stentsest. 2008Vascular DynamicsMountain View, CA, US · est. 2008

Vascular Dynamics: US-based medical product provider specializing in stent implants for hypertension.

Series B · $105.1M24
MicroPort ScientificMicroPort ScientificShanghai, Shanghai, CNMedical Devicesest. 1998MicroPort ScientificShanghai, Shanghai, CN · est. 1998

MicroPort: A global Chinese healthcare firm specializing in minimally invasive devices for vascular, diabetes, and orthopedic treatments.

Public · $1.3M9k
AccuVeinAccuVeinMedford, NY, USMedical Devicesest. 2006AccuVeinMedford, NY, US · est. 2006

AccuVein designs innovative solutions for enhanced peripheral vasculature visualization.

Series B · $69.3M110
OraSure Technologies
OraSure Technologies

Bethlehem, PA, US

Board Member· Board
Syncromune
Syncromune

Fort Lauderdale, FL, US

CEO· C-Suite · Management

Eamonn Hobbs's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Eamonn Hobbs

Andrew FerenciAndrew FerenciFounder · ComradEugene LuskinEugene LuskinCo-Founder · SyncJeff ChouJeff ChouCEO · SonatusThomas OxleyThomas OxleyCo-Founder · SynchronWilliam D KernsWilliam D KernsCEO · SynchroneuronBrian EnrightBrian EnrightBoard Member · Syncreon